Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Precancerous Conditions 1Melanoma 1Hepatitis C 1

Interventions

Polymerase Chain Reaction 4Immunohistochemistry 4Biopsy 4Surveys and Questionnaires 3Microarray Analysis 3Gene Expression Profiling 3Blood Specimen Collection 3Mass Spectrometry 2Interviews as Topic 2In Situ Hybridization, Fluorescence 2Cytogenetic Analysis 2Comparative Genomic Hybridization 2tremelimumab 1Watchful Waiting 1Vaginal Smears 1Ultrasonography, Doppler 1Tomography, Optical Coherence 1Tamoxifen 1Surgical Procedures, Operative 1Ribavirin 1Radioimmunodetection 1Pharmaceutical Preparations 1Papanicolaou Test 1Observation 1Molecular Diagnostic Techniques 1Methylation 1Infliximab 1Immunoenzyme Techniques 1Histological Techniques 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Ribavirin × Other neoplasm × Clear all
NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Vanderbilt-Ingram Cancer Center

Terminated
7 enrolled
DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡